Impact of BAL lymphocytosis > 15% on the prognosis of chronic idiopathic interstitial pneumonias other than idiopathic pulmonary fibrosis: a retrospective nationwide study based on multidisciplinary discussion

A. Yamagata (Okayama, Japan), M. Arita (Okayama, Japan), F. Tokioka (Okayama, Japan), C. Sugimoto (Osaka, Japan), H. Sumikawa (Osaka, Japan), T. Tanaka (Hyogo, Japan), H. Yasui (Shizuoka, Japan), T. Fujisawa (Shizuoka, Japan), Y. Nakamura (Shizuoka, Japan), T. Suda (Shizuoka, Japan), T. Ishida (Okayama, Japan)

Source: Virtual Congress 2020 – Prognosis and biomarkers of idiopathic pulmonary fibrosis

Session: Prognosis and biomarkers of idiopathic pulmonary fibrosis
Session type: E-poster session
Number: 824

Disease area: Interstitial lung diseases

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Yamagata (Okayama, Japan), M. Arita (Okayama, Japan), F. Tokioka (Okayama, Japan), C. Sugimoto (Osaka, Japan), H. Sumikawa (Osaka, Japan), T. Tanaka (Hyogo, Japan), H. Yasui (Shizuoka, Japan), T. Fujisawa (Shizuoka, Japan), Y. Nakamura (Shizuoka, Japan), T. Suda (Shizuoka, Japan), T. Ishida (Okayama, Japan). Impact of BAL lymphocytosis > 15% on the prognosis of chronic idiopathic interstitial pneumonias other than idiopathic pulmonary fibrosis: a retrospective nationwide study based on multidisciplinary discussion. 824

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Predicting survival in newly diagnosed idiopathic pulmonary fibrosis: a 3-year prospective study Source: Eur Respir J 2012; 40: 101-109 Year: 2012
Incidence and prevalence of idiopathic pulmonary fibrosis: review of the literature Source: Eur Respir Rev 2012 21: 355-361 Year: 2012
Management of patients with idiopathic pulmonary fibrosis in clinical practice: the INSIGHTS-IPF registry Source: Eur Respir J 2015; 46: 186-196 Year: 2015
Clinical outcomes of patients with idiopathic pulmonary fibrosis in clinical practice: Follow-up results of the INSIGHTS-IPF registry Source: International Congress 2015 – IPF: clinical aspects II Year: 2015
Clinical-pathologic study on small airways in patients with idiopathic interstitial pneumonia Source: Annual Congress 2009 - Clinical aspects of diffuse parenchymal lung disease Year: 2009
A global perspective on acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF): results from an international survey Source: International Congress 2018 – Clinical news in idiopathic interstitial pneumonias Year: 2018
PROOF-registry: A prospective observational registry to describe the disease course and outcomes of IPF patients in a real-world clinical setting- An interim report Source: International Congress 2015 – IPF: clinical aspects Year: 2015
PROOF: A prospective observational registry to describe the disease course and outcomes of idiopathic pulmonary fibrosis patients in a real-world clinical setting in Belgium and Luxembourg: Exposure in the interim report of 175 IPF patients Source: International Congress 2016 – IPF clinical Year: 2016
Nutritional assessment in patients with idiopathic pulmonary fibrosis: the NUTRIPF study Source: Virtual Congress 2021 – Interstitial lung disease around the world Year: 2021
Effectiveness of a community based pulmonary rehabilitation (PR) programme for patients with chronic obstructive pulmonary disease (COPD): A retrospective review Source: International Congress 2017 – Best abstracts in pulmonary rehabilitation in patients with chronic lung diseases Year: 2017
Considerations of a warm autopsy program for patients with idiopathic pulmonary fibrosis Source: Annual Congress 2010 - Clinical issues in diffuse parenchymal lung disease Year: 2010
Management of idiopathic pulmonary fibrosis: selected case reports Source: Eur Respir Rev 2014; 23:239-248 Year: 2014
Does delay in review of newly-diagnosed idiopathic pulmonary fibrosis (IPF) worsen outcomes? Source: International Congress 2018 – News on the diagnosis of idiopathic interstitial pneumonia Year: 2018
Long-term evaluation of home-based pulmonary rehabilitation in patients with fibrotic idiopathic interstitial pneumonias Source: ERJ Open Res, 5 (2) 00045-2019; 10.1183/23120541.00045-2019 Year: 2019
Validation of GAP score in Danish patients diagnosed with idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Diffuse parenchymal lung disease II Year: 2013
Initial clinical experience with nintedanib for treatment of idiopathic pulmonary fibrosis (IPF): About 20 cases Source: International Congress 2015 – IPF: from bench to bedside Year: 2015
Onset of symptoms in idiopathic pulmonary fibrosis: A case-control study Source: International Congress 2016 – IPF: from pathogenesis to treatment I Year: 2016
Biopsy documented idiopathic interstitial pneumonias - Analysis of diagnostic yield, survival and mortality over 9 years Source: Annual Congress 2013 –Interventional procedures for diagnosis of diffuse lung diseases and peripheral pulmonary lesions Year: 2013
Clinical impact of an interstitial lung disease Nurse on patients with idiopathic pulmonary fibrosis Source: International Congress 2018 – What is new in idiopathic interstitial pneumonias? Year: 2018
Acute exacerbation of idiopathic pulmonary fibrosis: international survey and call for harmonisation Source: Eur Respir J, 55 (4) 1901760; 10.1183/13993003.01760-2019 Year: 2020